Bioanalytical systems based on the Bioluminescence Resonance Energy Transfer (BRET) are widely used in fundamental biochemical studies, as well as for screening and analysis of biologically active compounds. The Renilla luciferase is the most often used energy donor in this system despite the fact that it has low bioluminescence quantum yield and demonstrates not so stable luminescence in time as the firefly luciferase. Moreover, the bioluminescence λ max is observed in the green region of the spectrum, which complicates signal recording in tissues during in vivo experiments. The firefly luciferases do not have such drawbacks and show great promise for applications in BRET systems. Different versions of BRET systems based on firefly luciferases and the methods for increasing their efficiency are considered in this review; examples of the use of BRET systems based on the firefly luciferases for highly sensitive determination of proteases and for homogeneous immunoassays are presented.
GENERAL CONCEPT OF THE METHOD
Resonance energy transfer (RET) is a phenomenon of non-radiative transfer of energy from donor to acceptor that is observed when both entities are in close proximity to each other within 10 nm. Overlap of the emission spectrum of the donor with the absorption spectrum of the acceptor is required for the RET realization, and relative orientation of the donor and acceptor dipoles must not be at 90° angle.
The efficiency of energy transfer is described by the equation:
E RET = 1 1+ (r / R 0 ) 6 
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where r is the distance between donor and acceptor, R о -(characteristic distance at which the efficiency of the transfer is 50%). The R о values (20 -50 Ǻ) are determined from the equation:
where J is spectral overlap integral of the donor emission spectrum and the acceptor absorption spectrum, к -parameter depending on the dipole orientation, Q D -quantum yield of the donor emission, ε -extinction coefficient of the acceptor (М -1 сm -1 ) [1] .
The RET is essentially manifested as the change of the recorded emission spectrum: decreasing of the donor emission intensity and emerging of the acceptor emission spectrum. The use of the donor-analyte and acceptor-other analyte hybrid proteins (or conjugates) opens up possibilities for monitoring of both intermolecular interactions and *Address correspondence to this author at the Faculty of Chemistry, Lomonosov Moscow State University, Moscow, 119992, Russia; Tel: +7-495-939-26-60; Fax: 7-495-939-26-60; E-mail: nugarova@gmail.com conformational changes in the molecule provided that the donor and the acceptor are localized on different parts of it with the distance between them changing during conformational transformations. The value of the RET-signal is characterized by the ratio of the acceptor emission intensity to the donor emission intensity.
In the case when a bioluminescent enzyme (luciferase) is used as a donor, the resonance transfer is termed a bioluminescence resonance energy transfer (BRET). The BRET process was found in nature in marine organisms such as the sea pansy Renilla reniformis and the jellyfish Aequorea victoria. In these cases the green fluorescent protein plays a role of the acceptor, and the Renilla luciferase (Rluc) and the aequorin, respectively, of the donors [2] .
The use of luciferases as donors presents a number of advantages over the traditional fluorescence resonance energy transfer (FRET) where the fluorescent protein is used as a donor. The external light source is not required in ВRET and, hence, all the light emitted by the acceptor is the result of the transfer of the bioluminescence energy. The absence of external light source prevents the sample photobleaching and opens opportunity to work with the light-sensitive cells as well as with cells possessing significant autofluorescence. The higher sensitivity of the BRET signal recording allows working with lower protein concentrations, which minimizes the effect of non-specific interactions in addition to some economic advantages.
For example, Arai et al. used the heavy and light chains of the antibody variable domains labeled with luciferase and fluorescent protein as donor and acceptor, respectively [3] instead of the pair of blue and green fluorescent proteins used in the FRET system. It was possible in this case to decrease the concentration of donor 40-fold, and of acceptor -3-fold. This resulted in the decrease of the limit of detection of the antigen by two orders of magnitude (0.8 µМ for FRET and 7 nM for BRET) [4] . And finally, instrumentation required for the BRET detection is simpler and less expensive than for the FRET as it does not require light sources for donor excitation.
The main challenge during the development of BRET systems is the correct selection of the donor-acceptor pair with good resolution between the emission spectra of the donor and the acceptor and with maximum overlap between the emission spectrum of the donor and the absorption (excitation) spectrum of the acceptor.
BRET-SYSTEMS BASED ON RENILLA LUCIFERASE
The first BRET application was presented in 1999. Xu et al. investigated interaction (homodimerization) of KaiA and KaiB proteins encoded by circadian genes in cyanobacteria. The Renilla luciferase (λ max,em = 480 nm) was used as the donor, and the yellow fluorescent protein (mutant of the green fluorescent protein, λ max.ex = 511 nm, λ max.em = 525 nm) -as the acceptor [5] . From this point on the number of publications using the Renilla luciferase started to increase steeply [6, 7] . New luciferase substrates and various mutant forms of both the Renilla luciferase and yellow fluorescent proteins with improved characteristics emerged. The following versions of BRET can be identified based on the donor-acceptor pairs: BRET1 -classic version using coelenterazine as the substrate for the Renilla luciferase (λ max.em = 480 nm) paired with the yellow fluorescent protein (λ max.em = 530 нм) and its various modifications [5] ; BRET2 -version using the DeepBlueC substrate -chemical derivative of coelenterazine (the bioluminescence spectrum of Renilla luciferase shifts in this case towards the blue region (λ max.em = 395 nm)), paired with different variants of the acceptor -green fluorescent protein (λ max.ex = 400 nm, λ max.em = 510 nm) [8] . BRET2 demonstrates better spectral resolution of the bioluminescence maximum and the acceptor emission maximum in comparison with the BRET1. This is important for the screening analysis when the high signal-to-noise ratio is required. The BRET2 drawback is in the fact that the use of the DeepBlueC substrate results in 300-fold decrease of the bioluminescence intensity. It was possible to partially alleviate this problem by introducing the Rluc8 mutant form [9] , quantum yield of which was 32-fold higher than that of the native Renilla luciferase, nevertheless, the bioluminescence signal was still lower than in the BRET1.
USE OF FIREFLY LUCIFERASE IN BRET-SYSTEMS
Despite the ceaseless interest to the Renilla luciferase it has number of drawbacks such as low bioluminescence quantum yield and reduced time-stability of the emission in comparison with the firefly luciferase; the λ max of the bioluminescence spectrum is in the green region. The detection of signal in tissues during in vivo experiments is made difficult due to the low penetration of green light. Moreover, the level of autofluorescence of cells in the green region is higher than in the region of the spectrum characteristic for the firefly luciferase bioluminescence (λ max.em = 540 -630 nm depending on the structure of the enzyme) [10] . The fact that it is easy to express firefly luciferase in large quantities in E. сoli cells represents an important advantage of this enzyme. As of now, numerous mutant forms of firefly luciferase are described differing in the bioluminescence spectra, as well as demonstrating high thermal stability [11] .
The first studies using firefly luciferase (λ max.em = 560-580 nm) as the donor were published in 2002 [12] . These systems were termed BRET3 [13] . The emergence of red fluorescent proteins (λ max.ex = 558 nm, λ max.em = 583 nm) made it possible to develop BRET-systems based on firefly luciferase for the analysis of protein-protein interactions in vivo [14] . Arai et al. were the first to obtain the hybrid protein luciferase-glutathione-S-transferase for the BRETsystem based on the firefly luciferase [12] . The hybrid protein of the red fluorescent protein (DsRed) with protein G was used as the acceptor. It was not possible, however, to achieve high sensitivity using this BRET system because of the high background signal that was due to the low resolution of the luciferase bioluminescence spectrum and the emission spectrum of the red fluorescent protein, as well as because of the low BRET signal detected over this background.
The dyes with different spectral characteristics, extinction coefficients, fluorescence quantum yields, and possibility of their modification with functional groups represent another family of acceptors for the firefly luciferases. In order to achieve high BRET signal, the acceptor must have high extinction coefficient, solubility in the reaction mixture suitable for conjugation with the specific molecule, demonstrate maximal spectral overlap integral of the absorption spectrum of the dye and the luciferase bioluminescence spectrum. The coumarin and rhodamine dyes can be used as acceptors, but as a rule they have relatively low extinction coefficients (ε = 20000 -60000 М -1 сm -1 ), while the cyanine dyes demonstrate higher extinction coefficients (ε = 150000 -250000 М -1 сm -1 ). Specifically, the Alexa Fluor® dyes that are derivatives of the above mentioned dyes have the highest fluorescence quantum yield and are stable and soluble in water due to the availability of sulfo group in their structure [15] .
Despite the large variety of available dyes, only few studies are known that are using dyes as acceptors for the BRET3. One of the possible reasons for this is the necessity of their chemical conjugation with one of the partners of the investigated interaction, which may have its own limitations such as composition heterogeneity and partial or even complete loss of the specific activity of the obtained conjugates. Yamakawa et al. [16] developed BRET-system for competitive analysis of the myc-peptide. The glutathione-S-transferase-myc-peptide-firefly luciferase hybrid protein was used as a donor and antibodies labeled with cyanine dyes -as acceptors. The cyanine dyes with different spectral overlap integrals of the dye absorption spectrum with the luciferase bioluminescence (λ max.em = 550 nm) were used: Cy3 (λ max.em = 570 nm), Cy3.5 (λ max.em = 596 nm), and Cy5 (λ max.em = 672 nm). Only the bioluminescence quenching without the changes of the spectrum was observed for the Cy5 dye. In the case of the Cy3 dye, the calibration curve had narrow dynamic range and high background signal. The lower background signal and wider dynamic range of the BRET-signal change were observed for the Cy3.5 in comparison with the Cy3 dye. The range of the measurable concentrations of the myc-peptide was 0.2 -2 μM with the change of the BRET signal (the ratio of the emission intensities at 596 and 550 nm) from 0.2 to 0.8. Sequential resonance energy transfer based on firefly luciferase As was mentioned above, the use of firefly luciferase as a donor and red fluorescent protein as an acceptor is quite problematic due to the high bioluminescence signal at the wavelength of the acceptor emission. The method for improving the resolution between the maximum of the luciferase bioluminescence and the acceptor emission was suggested by Branchini et al. [17] and was termed as sequential resonance energy transfer (SRET), which combined two sequential transfer steps: BRETtransfer followed by FRET-transfer (Fig. 1) . In this case the acceptor -red fluorescent protein mKate S158A (λ max.ex = 585 nm, λ max.em = 625 nm) -was modified with the AF-680 dye (λ max.ex = 680 nm, λ max.em = 705 nm). The additional FRET step from the excited red fluorescent protein to the dye was added in the process, and thus the dye fluorescence was recorded. The emission spectrum of the dye was shifted significantly towards the red region and did not overlap with the spectrum of the luciferase bioluminescence. Hence, essentially the complete resolution of the emission peaks of the donor and the acceptor was observed. The high efficiency of FRET (total absence of the emission of the red fluorescent protein) should be emphasized, which was due to the minimal distance between the fluorescent protein and the covalently bound dye.
When the specific recognition sites for proteases were introduced between the BRET donor and acceptor, the highly sensitive sensors for detection of protease activity and their quantitative determination were obtained. The minimum detectable concentration were 0.41 nM for caspase-3, 1 nM for thrombin, and 58 nM for factor Xa [17] .
Optimization of BRET-systems based on firefly luciferase for detection of proteases. Branchini et al. [18] produced mutant P. pyralis luciferases that contained one and two cysteine residues on the surface, which were used for conjugation with the Alexa Fluor® nIR dyes (AF-dyes). It was shown that the BRET signal increased ~5-to 9-fold (up to 1:4) for the mutants containing one cysteine residue (in position 399 or 169) in comparison with the initial luciferase due to the positioning of the dye molecule closer to the active site of the luciferase by 15 Ǻ. The BRET signal increased up to 1:34 when two cysteine residues were introduced (mutant T169C; S399C), which was 8.5-fold more effective than when the quantum dots were used as acceptors (1:4) [18] . Other factors affecting the efficiency of energy transfer are orientation of the dye dipoles and their fluorescence quantum yield. For example, the BRET efficiency was 8.5-fold higher for the AF-680 dye with the fluorescence quantum yield of 0.36 in comparison with the AF-750 dye that demonstrated 3-fold lower quantum yield. The conjugate of the biotinylated mutant luciferase (hybrid luciferase-biotin-binding domain) with the AF-680 dye was obtained that contained a 12-amino acid linker. This linker contained the sequence of the specific cleavage site for the factor Xa protease. This provided possibility for measuring the factor Xa activity in blood at physiological concentrations. The efficiency of BRET for the hybrid protein modified with the dye was 1:14, however, the luciferase activity decreased to 70% of the same luminescent enzyme but not containing the biotin-binding domain.
Quantum dots as acceptors of luciferase bioluminescence.
Quantum dots (QDs) -semiconductor nanocrystals with especially wide excitation spectrum (from UV to 530 nm) -are effective acceptors for BRET systems. The emission maximum of quantum dots depends on the diameter of nanoparticles and can be observed in different regions of the spectrum from blue to near infrared [19] . Alam et al. studied BRET between the Р.рyralis firefly luciferase (Ppy) and core/shell semiconductor quantum rods (QRs) as a function of the QR aspect ratio and internal microstructure. The distances from the Ppy to core were optimized, and the measured BRET ratios of > 44 were the highest efficiencies reported to date [20] .
BRET-based systems for quantitative analysis can be subdivided into two types. The first type, which is the most common and widely used, includes the systems where irreversible separation of the donor/acceptor pair occurs in the presence of analyte. As a rule, such systems are employed for determination of proteases activities, in which donor and acceptor are connected via linker containing specific sequence of the cleavage site. The BRET signal decreases under the action of proteases. The vast majority of such systems was developed on the basis of Renilla luciferases and its mutant forms [21] . Only a few above mentioned studies are known that use firefly luciferase [17] . The systems in which, on the contrary, association of the donor and acceptor occurs in the presence of analyte belong to the second type; in this case the BRET signal either emerges or increases. The systems investigating posttranslational modifications [22] , detecting various effectors inducing interaction between the donor and acceptor, monitoring of the ligands binding to the receptors and thus initiating intracellular signal transduction (insulin receptor) [23] , and many others [24] can be classified as such systems. For example, Yoshida et al. [25] developed a convenient histone modification detection system by combining a chromatin immunopercipitation (ChIP) and BRET-based homogeneous PCR product detection system using zinc finger fused to luciferase (ZF-luciferase) with DNA intercalating dye (ChIP-ZF-luciferase BRET assay). The authors concluded that this system may be useful and convenient for simultaneous detection of histone modification and DNA methylation in clinical diagnoses.
BRET-BASED IMMUNOASSAY USING FIREFLY LUCIFERASE
The homogeneous enzyme-linked immunoassay is one of the promising and less investigated areas among the bioluminescence resonance energy transfer (BRET) applications. BRET-based immunoassays provide a number of advantages over the classic heterogeneous immunoassays: 1) no separation and washing steps to remove unbound components are required, 2) the time of analysis is significantly shorter due to the fact that it is conducted in solution where the diffusion limitations are minimal. In common with the heterogeneous immunoassay, the homogeneous BRET-based immunoassay can be competitive and non-competitive.
In the course of non-competitive assay the proteins of the BRET system (donor and acceptor) are not bound in the absence of antibodies (antigen), and the energy transfer is not observed. Formation of the triple complex (donoracceptor -antibody (antigen)) occurs upon the addition of antibody (antigen) in the system. The donor and acceptor are brought together in the process so that the resonance energy transfer becomes possible, and the fluorescence signal emerges. The magnitude of the BRET signal is proportional to the concentration of the analyte of interest [4] .
Arai et al. developed the BRET-system based on the Hotaria parvula firefly luciferase (HpL). The hybrid protein glutathione-S-transferase-HpL (GST-HpL) was used as the donor, and the hybrid of the red fluorescent protein (DsRed) with the protein G (DsRed-PG) was used as the acceptor. In the absence of antibodies the hybrid proteins are in monomeric form, and the BRET is not observed. The addition of antibodies induces formation of the triple GSTHpL/Ab/DsRed-PG complex, which is accompanied by the emergence of the DsRed-PG fluorescence. This system was used for determination of concentration of anti-glutathione-S-transferase antibodies in the range 0.1 nM -1 μM [12] .
In the competitive immunoassay the conjugates of the analyte with either donor or acceptor and antibodies conjugated with the acceptor/donor of bioluminescence are used. The maximum BRET signal is observed in the absence of the free analyte, which is decreasing with the increasing concentration of the analyte of interest added to the system. Yamakawa et al. proposed a rapid and potentially sensitive homogeneous immunoassay of peptide epitope based on the BRET. A GST-peptide tag fused to the N-terminus of firefly luciferase, and Cy3 or Cy3.5-labeled anti-peptide antibody were prepared to detect BRET from the hybrid luciferase to the fluorophore-labeled antibody. The BRET signal is observed in the presence of the GST-myc-peptide-Luc hybrid protein and the colored antibodies, which is decreasing with the increase of the added myc-peptide concentration. The range of the detectable concentrations of the с-myc peptide was 0.2 -2 μM [16] .
Highly sensitive homogeneous immunoassay of the low molecular weight antigen was developed based on the BRET system with the mutant thermostable Luciola mingrelica firefly luciferase (Luc) as the donor and the Alexa Fluor 610-x dye (AF-610) as the acceptor [26] . As was indicated above, high quantum yield of the donor bioluminescence is required for the effective BRET. The L. mingrelica firefly luciferase fully meets this requirement, as it and other firefly luciferases have the highest quantum yield among the bioluminescent systems. Availability of the L. mingrelica firefly luciferase in sufficient quantities, its high catalytic activity and thermal stability also are of importance [27, 28] . Two thermostable mutants of the L. mingrelica firefly luciferase -"red" mutant with λ max.em = 590 nm (RLuc) and "green" mutant with λ max.em = 550 nm (GLuc) -were tested during the development of this BRET system (Fig. 2) . The RLuc luciferase was obtained and characterized earlier as described in [27] . Two additional mutations Y35N and S398M were introduced into the RLuc structure, which resulted in the shift of the bioluminescence maximum to the green region of the spectrum. The Alexa Fluor 610-x (AF-610) dye, which has two absorption maxima at 550 and 610 nm that are close to the bioluminescence maxima of the GLuc and RLuc, respectively, was selected as the acceptor, which provided optimal spectral overlap integral between the bioluminescence spectra of both luciferase mutants used and the dye absorption spectrum. Among the known dyes with similar spectral characteristics the AF-610 demonstrates the highest extinction coefficient (138 000 M -1 cm -1 ) and higher fluorescence quantum yield in comparison with the cyanine dyes used in [16] . Moreover, the AF-610 contains sulfo group in its structure and, hence, is water soluble, which represents a significant advantage because it is preferable to conduct the reaction of antibody conjugation in aqueous solution.
The analysis of the RLuc and GLuc bioluminescence spectra and the AF-610 absorption spectrum showed that the ratio of the spectral overlap integral between the bioluminescence spectrum of the luciferase and the absorption spectrum of the dye to the integral of the bioluminescence spectrum was higher for the Gluc luciferase than for the RLuc (83.7 and 78.5%, respectively). Furthermore, the value of the residual bioluminescence of the donor at the wavelength of the fluorescence maximum of the acceptor (630 nm) (background signal) is of importance. The bioluminescence signal of the RLuc at 630 nm constituted 57% of the maximum signal (at 590 nm), while it was only 15% for the GLuc. Consequently, the background bioluminescence intensity in the case of GLuc was 4-fold less than for the RLuc. Hence, the GLuc was proved to be more suitable for the use in this BRET system. The optimized method of synthesis allowed producing conjugate of the luciferase with progesterone (GLuc-Pg), which contained 3 molecules of Pg per one GLuc molecule, retained ~70 % of the luciferase activity, and demonstrated high antibody binding ability, which was tested with the enzyme-linked immunoassay.
Conjugates of the rabbit polyclonal anti-progesterone antibodies with the dye (Ab-AF610), which were produced upon interaction of amino groups of antibodies with the succinimide derivative of the dye, were used as the acceptor. The ability of conjugates to bind the antigen as well as the ability to serve as acceptor in the BRET system (magnitude of BRET signal) depended on the Ab:Fl ratio in the composition. The conjugate with the Ab:AF-610 composition of 1:10 was found to be optimal for both antigen binding and the BRET recording. Optimization of the reaction conditions, composition of the reaction mixture, concentrations of the donor and acceptor allowed reaching of the minimum detectable concentration of progesterone that was equal to 0.5 ng/ml (1.7 nM). The dynamic range of the measurable concentrations of progesterone was 0.5 -30 ng/ml (Fig. 3) . Fig. (3) . Dependencies of the specific BRET signal on concentration of free progesterone for the GLuc-Pg conjugate (curve 1), and of non-specific signal for the initial luciferase GLuc (curve 2).
Hence, the minimum detectable concentration of analyte shown in [26] was 6-fold lower than the one reported in [16] .
The high sensitivity of the homogeneous BRET-based immunoassay for the progesterone was close to the sensitivity of the heterogeneous competitive immunoassay for progesterone using the same conjugates GLuc-Pg and Ab-AF-610 (0.3 ng/ml). The main advantage of the homogeneous method is that it is less time-and laborconsuming (20 min instead of 1-2 h), which is important for increasing productivity of bioanalytical systems especially when screening studies are conducted. 
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